The overexpression of PARP1 has been found in different cancers including GBM; indeed, it has been demonstrated that PARP inhibitors, alone or in combination with chemotherapeutic agents, induced promising effects against tumors harboring DNA repair defects [45]. The gene discussed is PARP1; the disease is glioblastoma.